Drug repurposing for duchenne muscular dystrophy: the monoamine oxidase b inhibitor safinamide ameliorates the pathological phenotype in mdx mice and in myogenic cultures from dmd patients

HIGHLIGHTS

  • who: Marcella Canton from the Department of Biology, University of Padova, Padova, Italy, Interuniversity Institute of Myology, Padova, Italy, Venetian have published the research: Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in mdx Mice and in Myogenic Cultures From DMD Patients, in the Journal: (JOURNAL)
  • what: The authors investigate for the first time the specific role of MAO-B in cultured muscle cells from DMD Frontiers in Physiology | www.frontiersin.org Building on the previous findings, this study provides two novel aspects: (i) in the context . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?